rs3889063
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_021098.3(CACNA1H):c.5207G>A(p.Arg1736His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000447 in 1,611,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1736C) has been classified as Uncertain significance.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.5207G>A | p.Arg1736His | missense_variant | Exon 30 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.5222G>A | p.Arg1741His | missense_variant | Exon 29 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.5225G>A | p.Arg1742His | missense_variant | Exon 29 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.5189G>A | p.Arg1730His | missense_variant | Exon 29 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.5222G>A | p.Arg1741His | missense_variant | Exon 30 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.5207G>A | p.Arg1736His | missense_variant | Exon 30 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.5168G>A | p.Arg1723His | missense_variant | Exon 30 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.5189G>A | p.Arg1730His | missense_variant | Exon 29 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.5150G>A | p.Arg1717His | missense_variant | Exon 29 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.5207G>A | p.Arg1736His | missense_variant | Exon 30 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.5189G>A | p.Arg1730His | missense_variant | Exon 29 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.5207G>A | p.Arg1736His | missense_variant | Exon 30 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.5207G>A | p.Arg1736His | missense_variant | Exon 30 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.5207G>A | p.Arg1736His | missense_variant | Exon 30 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.5207G>A | non_coding_transcript_exon_variant | Exon 30 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*1159G>A | non_coding_transcript_exon_variant | Exon 29 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*288G>A | non_coding_transcript_exon_variant | Exon 30 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*3058G>A | non_coding_transcript_exon_variant | Exon 30 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4651G>A | non_coding_transcript_exon_variant | Exon 28 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.5189G>A | non_coding_transcript_exon_variant | Exon 29 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.5189G>A | non_coding_transcript_exon_variant | Exon 29 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*208G>A | non_coding_transcript_exon_variant | Exon 30 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.5207G>A | non_coding_transcript_exon_variant | Exon 30 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.5207G>A | non_coding_transcript_exon_variant | Exon 30 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.5189G>A | non_coding_transcript_exon_variant | Exon 29 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.5207G>A | non_coding_transcript_exon_variant | Exon 30 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.5207G>A | non_coding_transcript_exon_variant | Exon 30 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*208G>A | non_coding_transcript_exon_variant | Exon 29 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*1159G>A | 3_prime_UTR_variant | Exon 29 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*288G>A | 3_prime_UTR_variant | Exon 30 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*3058G>A | 3_prime_UTR_variant | Exon 30 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4651G>A | 3_prime_UTR_variant | Exon 28 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*208G>A | 3_prime_UTR_variant | Exon 30 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*208G>A | 3_prime_UTR_variant | Exon 29 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152222Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000286 AC: 7AN: 244798 AF XY: 0.0000225 show subpopulations
GnomAD4 exome AF: 0.0000473 AC: 69AN: 1459548Hom.: 0 Cov.: 35 AF XY: 0.0000510 AC XY: 37AN XY: 726028 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152222Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74358 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CACNA1H protein function. ClinVar contains an entry for this variant (Variation ID: 460140). This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. This variant is present in population databases (rs3889063, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1736 of the CACNA1H protein (p.Arg1736His). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at